Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-08-31 LAWLOR AUGUSTINE Director Returned to the company −24.57 0
2023-08-31 LAWLOR AUGUSTINE Director Returned to the company −24.22 0
2021-10-01 LAWLOR AUGUSTINE Director Grant or award +5,839 24,573
2021-07-01 LAWLOR AUGUSTINE Director Grant or award +5,542 18,734
2021-06-09 LAWLOR AUGUSTINE Director Grant or award · Stock Option (Right to Buy) +14,000 14,000
2021-04-01 LAWLOR AUGUSTINE Director Grant or award +4,761 13,192
2021-01-05 LAWLOR AUGUSTINE Director Grant or award +3,417 8,431
2020-10-01 LAWLOR AUGUSTINE Director Grant or award +5,014 5,014
2020-07-01 LAWLOR AUGUSTINE Director Grant or award +3,673 24,215
2020-06-11 LAWLOR AUGUSTINE Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2020-04-01 LAWLOR AUGUSTINE Director Grant or award +4,934 20,542
2020-02-25 LAWLOR AUGUSTINE Director Sale −69,401 $6.10 $424K 0
2020-01-02 LAWLOR AUGUSTINE Director Grant or award +3,166 15,608

Page 1 of 1 · 13 trades